Moreover, the observed increase of CB2 and TRPV1 protein expression levels let us suppose that these receptors could also be interesting remarkable targets to suppress the altered inflammatory state and potentially to counteract inflammatory-related pain in SCD patients. This evidence concerns the gene CNR2 and Schnyder corneal dystrophy.